Summary. For nearly 70 years apoptosis has been known to be a form of cell death distinct from necrosis as well as an important regressive event during the normal development of the nervous system. For example, in the chick, mouse, rat and human approxiamately 50% of postmitotic neurons die naturally during embryonic or fetal development. It is generally accepted that neurons die during this period by apoptosis. After the period of naturally occurring cell death, the surviving neurons may undergo degeneration and death due to injury or disease later either during development or in adulthood. Recently, apoptosis has been suggested to be involved in the abnormal neuronal death that occurs following axonal injury or in neurodegenerative diseases such as amyotrophic lateral sclerosis and Alzheimer's. Although little is known about the etiology of these diseases, progress is steadilly being made toward understanding their underlying mechanisms. For diseases of spinal motoneurons, during the past two years gene mutations have been identified in patients with familial amyotrophic lateral sclerosis or spinal muscular atrophy. Furthermore, a number of in vitro, in vivo, and mutant animal models have been developed in order to study the factors which control motoneuron survival and/or death. Here, we review the morphological differences between necrotic and apoptotic cell death and some of the methods used to differentiate the two pathways. We also discuss motoneuron cell death during development, following injury and in disease, and its prevention by different agents, including neurotrophic factors.
Apoptosis is a form of normal cell death during development that has been recognized for some time as being morphologically different from necrosis (ERNST, 1926; GLUCKSMANN, 1951 GLUCKSMANN, , 1965 . Currently, apoptosis is a rapidly growing and active field of investigation, and much of this interest is likely due to the realiza- (MAJNO et al., 1960; KERR et al., 1972; CHU-WANG and OPPENHEIM, 1978; WYLLIE et al., 1980; CLARKE, 1990 , COHEN et al., 1992 BUJA et al., 1993) . The two cell death pathways can be distinguished histologically by examining changes in cell volume, membrane integrity, organelle swelling, and nuclear and chromatin condensation. There are also, however, some characteristics that appear to be similar in both major pathways of cell death.
Necrosis
Necrosis is a sequence of tissue and cellular events that occur in response to irreversible cell injury, eventually leading to cell death. On the tissue level, contiguous groups of cells can be affected simultaneously. On an individual cell level, two phenomena consistently underlie lethal cell injury: inability to reverse mitochondrial dysfunction (leading to depletion of ATP) and profound disturbance in membrane function and cell homeostasis. Accordingly, early loss of plasma membrane integrity is characteristic of necrotic cell death. When the plasma membrane is unable to regulate osmotic or ionic gradients, corresponding morphological changes occur in the cell. These include cellular edema, increased permeability to extracellular molecules, and ultrastructural discontinuity of the plasma membrane. Within the cytoplasm, as organelles begin to degenerate, mitochondria and endoplasmic reticulum swell, vacuoles form, and polysomes begin to detach from the endoplasmic reticulum. Eventually, the nucleus will become pyknotic, as chromatin condenses, and in the final stages of necrotic breakdown the shrunken chromatin will fragment (karyorrhexis) into numerous loosely associated particles, and the nucleus of the necrotic cell completely disappears. Numerous cells in close proximity can undergo these individual changes and together the entire mass of necrotic cells can follow one of several patterns. Coagulative necrosis is the most basic pattern and implies the initial preservation of the cellular outline. This type of necrosis typically occurs in solid organs such as the heart. At the other end of the spectrum liquef active necrosis results from the actions of lysosomal enzymes derived from within the cell itself (autolysis) or from other cells (heterolysis). Necrosis of this nature is generally seen in nervous tissue, such as in the brain following infarctions or ischemia. Ultimately, the necrotic cells will lyse and the debris is phagocytosed by inflammatory cells. This inflammatory response is a hallmark of death by necrosis.
Apoptosis
In contrast to necrosis, apoptosis usually occurs among scattered cells, rather than in contiguous groups of cells. Also, plasma membrane disruption is not an early feature of apoptosis. Rather, the cell begins to shrink, while the organelles remain remarkably intact, albeit more tightly packed. Nuclear chromatin also undergoes pyknosis similar to necrosis. In apoptosis, however, the chromatin condenses into a dense crescentshaped aggregate that marginates along the nuclear envelope (apoptotic figures), as opposed to the dispersed pyknotic particles found in nuclei undergoing necrosis. Pyknosis is also a relatively early event in apoptosis compared to necrosis. During chromatin condensation there is an activation of calcium-dependent endonucleases which act to cleave nuclear DNA at the linker regions between nucleosomes, producing a series of fragments that are multiples of 180-200 base pairs in length. Although these fragments cannot be observed histologically, by running DNA from apoptotic cells on an agarose electrophoresis gel, DNA bands separate and appear as the classic "laddering" of fragmented DNA. Although this DNA fragment laddering is commonly associated with apoptosis, it is not a requirement for all forms of apoptosis (CoHEN et al., 1992; OBERHAMMER et al., 1993; SCHWARTZ and OSBORNE, 1993; PEITSCH et al., 1994) . As apoptosis progresses, the plasma membrane eventually begins to form surface protuberances, apparently through the induction of transglutaminases that extensively crosslink cytoplasmic proteins. This cross-linking activity may serve to limit leakage of cellular contents (PIACENTINI et al., 1992) .
As these protuberances separate from the remainder of the cell, they form compact membrane-bound "apoptotic bodies" which are immediately phagocytosed by adjacent cells or macrophages, which help to avoid the occurrence of an inflammatory response.
The fate of apoptotic cells can also be further characterized at later stages based on the presence or absence of lysosomal activity and the origin of lysosomal action (CLARKE, 1990; OPPENHEIM, 1991; HOMMA et al., 1994) . If the cell is degraded by its own lysosomes, it is known as autophagocytosis.
A second category is heterophagocytosis, which involves lysosomal action derived from other cells. The third category is degeneration in absence of any detectable lysosomal activity. Based on these and other criteria, it is apparent that cell death is not a single, unified process but includes variants that may differ from the classic definition in both minor and major ways (CLARKE, 1990; SCHWARTZ and OSBORNE, 1993) .
METHODS

FOR DETECTING APOPTOSIS
The morphological changes described above can clearly be observed by transmission electron microscopy, and this method continues to be a reliable, though laborious technique for determining the mode of cell death. Biochemical methods have also been used to differentiate apoptosis from necrosis (SCHWARTZ and OSBORNE, 1995) . For instance, intranucleosomal DNA fragmentation, although not found in all cases of apoptosis, is considered to be a "hallmark" of the pathway (COMPTON, 1992) . Gel electrophoresis resolves DNA fragments creating a laddering pattern, each band separated by roughly 200bp. This is in contrast to the smear of DNA fragment sizes produced by the random degradation of DNA found in necrosis (WYLLIE, 1984) . The action of endonucleases during apoptosis exposes newly formed 3'DNA ends and enzymatic in situ techniques have been developed to label these ends, using terminal transferase labelling (TUNEL) (GAVRIELI et al., 1992; WIJSMAN et al., 1993) . The advantage of the TUNEL method is that it allows one to directly visualize apoptotic cells exhibiting DNA fragmentation in tissue sections or in vitro. One must be cautious when interpreting TUNEL results, however, since in the late phases of necrotic degradation DNA fragmentation also occurs, albeit as much larger fragments, and the TUNEL technique cannot distinguish between the two forms of degradation, although experiments have attempted to address this issue (GOLD et al., 1994) .
Other methods have attempted to quantify intact cells undergoing apoptosis using flow cytometry and fluorescence activated cell sorting (FACS). Using FACS, one can distinguish apoptotic cells from nonapoptotic cells based on the fluorescent differences in chromatin or cell volume. Also, by combining the fluorescent technique with immunophenotyping, it is possible to study apoptotic death in heterogeneous cell populations (TELFORD et al., 1994; SCHWARTZ and OSBORNE, 1995 Neurogenesis produces about twice as many neurons as are needed by'the adult nervous system (OPPENHEIM, 1991) , with the final number of neurons being achieved (Fig. 1) . Therefore, the actions of cell death complement the actions of cell birth in the regulation of cell numbers in the mature nervous system. Cell death is a normal and important refining process in the development of the nervous system that serves numerous adaptive functions, including removal of redundant neurons, error correction, system matching, removal of aberrant cell phenotypes, and the formation of sexually dimorphic structures (for reviews see OPPENHEIM, 1991; HOUENOU and OPPENHEIM, 1994) . The phenomenon of massive neuronal cell loss is wellconserved across species, and most regions and cell populations in the nervous system exhibit this normal or naturally occurring form of programmed cell death (PCD). What are the factors that regulate naturally occurring cell death in the nervous system? In general, alterations in the size of the synaptic targets of innervating neurons modifies the number of surviving neurons; reducing target size (e. g. limb bud removal) results in fewer cells ( Fig. 1) , whereas increasing target size results in greater cell numbers (OPPENHEIM, 1991) . From this it has been suggested that the target is the source of molecular signals with survival promoting properties that are retrogradely transported to the cell body of the presynaptic neurons. Later, this theory was confirmed by the discovery of the prototypical neurotrophic agent, nerve growth factor (NGF) (LEVI-MONTALCINI and HAMBURGER, 1951; LEVI-MONTALCINI, 1987) . In addition to targetderived trophic agents, there is increasing evidence indicating that non-target derived factors (from afferent inputs, glia, or systemic hormones) may also serve an important role in the regulation of neuronal survival (OPPENHEIM, 1991; OKADO et al., 1992; KORSCHING, 1993; TRAVIS, 1994; LINDSAY, 1995) .
It may be useful here to briefly discuss the terminology of programmed cell death (PCD) and apoptosis. Originally the term programmed cell death emerged from studies in insect larva as specific muscle cells died during metamorphosis into the adult moth (LOCKSHIN and WILLIAMS, 1965) . From this perspective, PCD implies cell death which takes place within a developmental context, and is used synonymously with naturally-occurring or physiological cell death. Other researchers have recently applied the term to any cell death involving gene-mediated ("programmed") cell death. Apoptosis, literally meaning the seasonal falling of leaves, refers to a series of morphological changes (e. g., cell shrinkage and chromatin condensation), distinct from necrosis, eventually leading to cell death and is not necessarily bound within the context of development. Also, apoptosis is often associated with de novo gene expression and protein synthesis, as well as intranucleosomal DNA fragmentation, but these characteristics are not requirements for apoptosis (i. e cytotoxic T-lymphocyte, CTL, killing). Further complicating matters, not all PCD occurs by apoptosis (i. e. chick ciliary neurons during neurogenesis) (PILAR and LANDMESSER, 1976) . Therefore the terms PCD and apoptosis refer to distinct phenomena, are not necessarily synonymous and should not be used interchangeably (SCHWARTZ and OSBORNE, 1993) . In C. elegans, among the 11 genes involved in programmed cell death, ced-3 and ced-4 are absolutely necessary for cells to die, while activation of ced-9 blocks cell death (HORVITZ, 1994) . Mammalian homologs of some of these genes have been identified. For example, the mammalian genes, interleukin-lB-converting enzyme (ICE) and B-cell lymphoma/leukemia-2 (bcl-2), correspond to ced-3 and ced-9, respectively, in the nematode (for review see SCHWARTZ and OSBORNE, 1993; BARINAGA, 1994) . The ced-9 gene of C. elegans shares 23% homology with mammalian bcl-2 gene (HENGARTNER and HORVITZ, 1994) . Despite the vast differences between these species, human bcl-2 is able to prevent cell death in C. elegans (VAUx et al., 1992a) , demonstrating a remarkable degree of conservation from nematode to man. The bcl-2 gene has emerged as an important regulator of cell death. Bcl-2 can block apoptotic cell death under a variety of conditions (for reviews see REED, 1994; HOCKENBERRY, 1994) . Experiments conducted in vitro have shown that overexpression of bcl-2 proto-oncogene can prevent neuronal cell death induced by neurotrophic factor deprivation (GARCIA et al., 1992) . The protective actions of bcl-2 overexpression has been extrapolated from cell culture and tested in vivo. Overexpression of bcl-2 reduces normal PCD of facial motoneurons as well as motoneuron loss following postnatal axotomy (DUBOIS-DAUPHIN et al., 1994) . Although the mechanism by which bcl-2 prevents cell death is not known, there is evidence to support the idea that bcl-2 inhibits cellular damage caused by reactive oxygen species (OLANOW, 1993; HOCKENBERRY et al., 1993; KANE et al., 1993) .
Proteases and protease inhibitors in naturally occurring cell death ICE was recently ideentified as the mammalian homolog to the nematode cell death protein Ced-3 (YUAN et al., 1993) . Since then there has been growing interest in the possible role of proteases and their inhibitors in apoptosis. If Ced-3 or ICE protein is overexpressed in transfected rat fibroblasts, these cell are induced to die by apoptosis (MIURA et al., 1993) . The ability of these proteases to induce death may be generalized to other (serine) proteases such as thrombin, found in the clotting cascade. In fact, thrombin has been shown to induce the death of cultured neurons and astrocytes, whereas thrombin inhibitors blocked this cell death (VAUGHAN et al., 1994) .
Apparently, the action of these proteases are downstream from those events involved in the protective effect of bcl-2. Cytotoxic lymphocytes (CTL) induce apoptosis in target cells by release of granules. One enzyme found in these granules with similarities to ICE is known as granzyme B, fragmentin 2, RNKP-1 or CPP1 (SHI et al., 1992) . Interestingly, expression of bcl-2 offers no protection against CTL-induced death (VAUx et al., 1992b) .
Protease inhibitors can protect cells from the action of ICE-like proteases. Crm A, from the cowpox virus, is a serine protease inhibitor (serpin), which prevents the death of cultured chicken dorsal root ganglion cells induced by NGF withdrawal (GAGLIARDINI et al., 1994) . Another serpin, protease nexin-1 (PN-1), has been shown in vivo to prevent naturally occurring motoneuron death in the chick and axotomy induced cell death in the neonatal mouse (HOUENOU et al., 1995) . Serpins may also have clinical potential in treating neurodegenerative disorders such as Alzheimer's disease. It is known that in the brains of Alzheimer patients, free PN-1 protein is decreased, suggesting a possible negative correlation between low levels of PN-1 and Alzheimer's disease (WAGNER et al., 1989) . If this is indeed the case then administration of serpins may help to correct the deficit.
Neuronal cell death in disease
The death of specific subpopulations of neurons is common to neurodegenerative diseases such as Alzheimer's, amyotrophic lateral sclerosis (ALS), Huntington's, and Parkinson's. The pathoetiology of these diseases is still unknown. However, several hypotheses have been proposed to explain the mechanisms that might underlie these diseases including, the lack of or defects in trophic interactions between the neurons and their targets (APPEL, 1981) , the excess of glutamate and calcium (CHOI, 1992; LIPTON and ROSENBERG, 1994) , oxygen free radicals (HALLIWELL, 1992; OLANOW, 1993) , autoimmunity (APPEL et al., 1993) or combinations of the above (COYLE and PUTTFARCKEN, 1993) . Whatever the underlying mechanisms may be, it is possible that the final pathway of the cell death occurring in these diseases is apoptotic. Although it has yet to be proven, there is in fact increasing evidence to support the idea of apoptotic death in neurodegeneration (LAFERLA et al., 1993; JOHNSON, 1994; LINDVALL et al., 1994; POLLARD et al., 1994; RATAN et al., 1994) . Furthermore, tissue specimens taken from patients with Alzheimer's, ALS, Huntington's, and Parkinson's disease reveal biochemical processes suggestive of apoptosis (SU et al., 1994; HEDREEN et al., 1994) .
Important studies directed at understanding the genetic etiology of motor neuron diseases have uncovered genes associated with ALS and spinal muscular atrophy (SMA). These genes may play a causal role in these disease processes. Mutations in the Cu/ Zn superoxide dismutase (SOD) gene have been found in patients with familial ALS (DENG et al., 1993; ROSEN et al., 1993) . More recently, transgenic mice expressing a mutated SOD gene were generated that develop clinical signs analogous to those found in ALS patients (GURNEY et al., 1994; Ris et al., 1995) . This finding has reinforced the theory of oxidative sterss as being an important underlying mechanism for neurodegeneration.
It has also raised questions as to whether oxygen free radicals are involved in normal apoptosis (WOOD and YOULE, 1994) . Cultured cortical neurons, predisposed to oxidative stress by glutathione depletion, can be induced to undergo apoptosis (RATAN et al., 1994) .
Additional evidence includes the fact that bcl-2, capable of blocking many forms of apoptosis, is also able to block H202-induced apoptosis in cultured lymphocytes (HOCKENBERRY et al., 1993) .
The genetic aberrations associated with other motoneuron diseases are also beginning to be uncovered. Spinal muscular atrophy (SMA) is a congenital, progressive, and lethal disease that primarily afflicts the anterior horn cells of the spinal cord by causing cell degeneration and loss, followed by muscle atrophy and eventual paralysis. Two unrelated gene defects have been found to be associated with SMA: the survival motor neuron (SMN) gene (LEFEBVRE et al., 1995) and neuron apoptosis inhibiting protein (NAIP) (ROY et al., 1995) . It is still not known whether these genetic aberrations are causal. However, understanding the cellular ramifications of these genetic defects may provide additional information about the processes involved in motoneuron cell death associated with SMA. It may also provide insights into the mecha-nisms of other forms of motoneuron disease. Again, apoptosis as a death pathway is implicated in SMA by virtue of the fact that the NAIP gene has homology to baculoviral IAP (inhibitor of apoptosis) gene sequences.
Axotomy induced cell death
Even after the cessation of naturally occurring cell death, neurons continue to depend on contact with their targets for some time. Therefore, they remain vulnerable if separated from their targets. For example, nerve section performed in mammals within the first week after birth still causes extensive motor neuron cell loss (CREWS and WIGSTON, 1990; SNIDER et al., 1992; LI et al., 1994) . However, adult motoneurons apparently do not die following axonal injury (SCHMALBRUCH, 1984; LAMS et al., 1988) . Axotomy in the adult is followed by responses (e. g. regeneration) which differ from those observed in neonates (for reviews see PRICE et al., 1990; VAUGHAN, 1990) . It is thought that, for a short period after PCD, neurons
have not yet gained trophic independence from their targets and that nerve section interrupts the retrograde transport of target-derived trophic agents thus depriving spinal neurons of survival promoting agents (LOWRIE and VRBOVA, 1992) . The mechanisms involved in axotomy-induced cell death are poorly understood, but evidence supports the hypothesis that axotomyinduced cell death is apoptotic. For instance, the structural and morphological changes in neurons following axotomy have common features (e. g. eccentric nuclear displacement, inf olding of the nuclear membrane, nuclear pyknosis) with neurons undergoing naturally occurring cell death (SNIDER et al., 1992) . Furthermore, data from examination of axotomized facial motoneurons suggest that axotomy-induced cell death may be apoptotic (ROSSITER et al., 1994) .
Axotomy-induced cell death is a relatively reliable and reproducible method that produces 50% or greater cell death in developing vertebrate animals. Accordingly, this method is being increasingly used as a biological system to test the biological actions of putative survival factors (SENDTNER et al., 1990; SNIDER et al., 1992; HOUENOU et al., 1994; LI et al., 1994; YAN et al., 1995; OPPENHEIM, 1995) . The time frame of axotomyinduced cell death of avian motoneurons differs significantly from that of mammals. In contrast to mammals, avian motoneurons are vulnerable (up to 50 of the cells are lost after axotomy) during embryonic development (i. e., on or before embryonic day 12) (HOUENOU et al., 1994) . In neonatal mice and rats, cell death following axotomy occurs within the first week after birth (HOUENOU et al., 1994; LI et al., 1994) . This difference most likely reflects a difference in maturation of precocial (chick) vs. altricial (mouse, rat) species.
Other models of neuronal cell death A number of investigators using in vivo and in vitro models to study the pathoetiology of neuron injury have begun to examine whether apoptotic cell death is involved. Many of these studies have revealed that apoptosis is a common pathway by which cells die in these models. A combination of in situ TUNEL staining and agarose gel electrophoresis of fragmented genomic DNA have shown that in vivo ischemiainduced cell death is apoptotic (HERON et al., 1993; MACMANUS et al., 1994) . In other studies of global ischemia, blocking protein synthesis reduces the extent of infarct (LINNIK et al., 1993) , suggesting that a portion of the ischemia affected neurons require de novo protein synthesis in order to die. Intra-amygdaloid injections of kainic acid, a glutamate agonist, results in what appears to be apoptotic cell death of CA3 hippocampal cells as accessed by in situ TUNEL labeling and DNA fragment laddering on electrophoresis gels (POLLARD et al., 1994) . In a transgenic model of Alzheimer's disease, mice overexpressing Af peptide demonstrate DNA fragmentation in situ by TUNEL histochemistry. Furthermore, histological examination of brain sections of these transgenic animals revealed that there was individual cell shrinkage and nuclear chromatin condensation and margination, indicative of apoptosis (LAFERLA et al., 1995) . The SOD transgenic mouse models for ALS have not yet been evaluated specifically for apoptotic cell death.
Studies in vitro have examined the ability of glutamate, calcium, and oxidative stress to induce apoptotic death of cortical neurons. These studies have shown that exposure of cultured cortical neurons to either glutamate or oxidative insults results in DNA fragment laddering evident on agarose gels (KURE et al., 1991; JOSEPH et al., 1993; RATAN et al., 1994) and morphological changes such as chromatin condensation (RATAN et al., 1994) . Also, co-culturing cortical neurons with transcription inhibitors prevents DNA fragmentation and cell death (KURE et al., 1991; RATAN et al., 1994) . Other studies have looked specifically at motoneuron cell death. In trophic factor deprivation experiments, cultured motoneurons require de novo transcription in order to die. These neurons also display the morphological features characteristic of apoptosis, and produce DNA fragments as evident by TUNEL and agarose gel electrophoresis (COMELLA et al., 1994; MILLIGAN et al., 1994) . In another in vitro model, immunoglobulins isolated from ALS patients were cultured with motoneuron-neuroblastoma hybrid cells. The resulting immunoglobulin-induced cell death appeared to be apoptotic as indicated by morphological features such as cell shrinkage and membrane blebbing and DNA fragmentation by in situ TUNEL and agarose gel electrophoresis (ALEXIANU et al., 1994) .
AGENTS
THAT PREVENT CELL DEATH
Neurotrophic agents
The first neurotrophic factor to be discovered, NGF (LEVI-MONTALCINI and HAMBURGER, 1951; LEVI-MONTALCINI, 1987) has been shown to regulate the survival of developing sensory and sympathetic neurons. This agent confirmed the prediction of investigators studying the occurrence and regulation of cell death in the chick embryo that some soluble agents produced in the target may be essential for neuronal survival. This gave rise to the neurotrophic hypothesis which linked the quantity of neurotrophic agents (limiting amounts) produced in the target to the regulation of cell death of the presynaptic neurons (OPPENHEIM, 1989) . The concept of NGF as a signal molecule which regulated the survival of sympathetic and sensory neurons initiated the search for molecules that acted on other neurons. Within the past few years, several other neurotrophic factors have been indentified, based either on their sequence homologies to NGF or on their survival activity on various neuronal cell types. These agents include brain-derived neurotrophic factor (BNDF), neurotrophin 3 (NT-3), neurotrophin 4/5 (NT-4/5), neurotrophin 6 (NT-6), ciliary neurotrophic factor (CNTF), insulin-like growth factors (IGF-1, IGF-2) and glial cell line-derived neurotrophic factor (GDNF). All these agents, except for NGF, have been shown to prevent motoneuron cell death either in vitro or in vivo during the period of PCD (ERIE et al., 1993; OPPENHEIM et al., 1993 OPPENHEIM et al., , 1995 THOENEN et al., 1993; GOTZ et al., 1994; HENDERSON et al., 1994; HOUENOU et al., 1994) . Motoneuron death that occurs following axotomy can also be prevented by treatment with these neurotrophic agents.
For instance, we have tested the ability of several neurotrophic agents to prevent lumbar motoneuron loss and have shown that NGF, BNDF, NT-3, CNTF, IGF-1, and GDNF can promote the survival of lumbar motoneurons in both the chick and neonatal mouse (HOUENOU et al., 1994; LI et al., 1994; OPPENHEIM et al., 1995) .
Based on the ability of neurotrophic agents to prevent neuronal cell death in vitro and in vivo, it has been proposed that these agents might have clinical potential in treating pathological neuronal cell death found in disease or following nerve trauma (DISTEFANO, 1993; THOENEN et al., 1993; HOUENOU and OPPENHEIM, 1994; LINDSAY et al., 1994) . As to their therapeutic potential in neurological diseases, there has not yet been any reports of cures or treatments beyond palliative management (SPRINGER, 1993) . The basis for using neurotrophic agents clinically to treat neurodegenerative diseases stems from their ability to rescue neurons in both the central and peripheral nervous system from PCD or injury-induced death. It has been suggested that disease such as Alzhemer's, Parkinson's and ALS are caused by deficiencies in neurotrophic interactions (production, uptake, utilization) between neurons and their targets (APPEL, 1981) . At present, however, none of these diseases have been shown to be associated with defects in any aspect of neurotrophic factor neurobiology. Even if these diseases are not caused primarily by such defects, however, treatment with neurotrophic agents may still be useful as pharmacological agents for preventing neuronal cell death resulting from either apoptosis or necrosis.
Administration of neurotrophic agents to genetic animal mutants that model some aspects of human motor neuron disease has shown that these agents are, in fact, able to prevent pathological motoneuron cell death. The autosomal recessive mouse mutants, progressive motor neuropathy (pmn) and wobbler (wr) are two such models. Administration of CNTF alone or in combination with BDNF has been shown to prevent the loss of motor function and cholinergic enzyme activity in the spinal cord of wr mice (MITSUMOTO et al., 1994) . Treatment with CNTF has also been to prolong the lifespan and improve motor function in pmm mice (SENDTNER et al., 1990) . A number of neurotrophic agents (e. g., CNTF, IGF-1, BDNF) have been or are currently in clinical trials in ALS patients. However, the long term survival effects of these neurotrophic agents is an issus that needs to be addressed.
In summary, apoptotic cell death is clearly emerging as an important and widespread phenomenon of cell death in disease and thus is not only limited to its well established role during development. The extent to which apoptosis is involved in various neurological disorders is still not clear. But since apoptosis is morphologically different from necrosis, this implies an underlying mechanistic difference between the two processes, and therefore blocking apoptosis provides another potential course for therapeutic intervention. However, new fundamental questions as to how apoptotic cell death differs from necrosis are also being uncovered. For example, many suggested triggering events (i. e., free radicals, calcium influx, proteolysis) for apoptosis have also long been considered as being involved in necrosis. Furthermore while the morphology of apoptosis is relatively consistent from system to system, it is not a unitary process. New gene or protein synthesis can be present or absent in apoptosis and even the eventual degradation of the cell body can differ. As a consequence some of the established dogmas which have differentiated apoptosis from other forms of cell death have begun to blur. Nevertheless, the new methods and techniques that complement established methods to study apoptosis will greatly facilitate the understanding of the extracellular factors that induce apoptosis as well as the genetic and proteolytic mechanisms of apoptosis. The future of apoptosis investigation is likely to yield a wealth of information that will not only provide insights for possible treatments for pathologic cell death but also insights into other fundamental aspects of cell biology, such as the potential links between apoptosis and mitosis (HEINTZ, 1993; RUBIN et al., 1993 Anat. Embryol. 181: 195-213 (1990 Rev. 26: 59-86 (1951) .
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